Methylphenidate Controlled-Release Tablets and Signifor LAR
Determining the interaction of Methylphenidate Controlled-Release Tablets and Signifor LAR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor LAR Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylphenidate Controlled-Release Tablets-Signifor LAR Injection
- Methylphenidate Controlled-Release Tablets-Siklos
- Methylphenidate Controlled-Release Tablets-Siladryl Allergy
- Methylphenidate Controlled-Release Tablets-Silalite Pak
- Methylphenidate Controlled-Release Tablets-Silapap
- Methylphenidate Controlled-Release Tablets-Sildec DM Syrup
- Signifor LAR-Methylphenidate ER Capsules
- Signifor LAR-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Signifor LAR-Methylphenidate Extended-Release Chewable Tablets
- Signifor LAR-Methylphenidate Extended-Release Oral Suspension
- Signifor LAR-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Signifor LAR-Methylphenidate Extended-Release Tablets